A research and technology hub at India’s Indian Institute of Technology Kharagpur has transitioned to a self-sustaining business model, ending its reliance on government grants to continue developing affordable medical devices.
The Common Research and Technology Development Hub on Affordable Healthcare, known as CRTDH, completed its shift to independent operation after successfully demonstrating that low-cost health technology innovation could survive without direct public funding. The facility now covers operational expenses through user fees, industry sponsorships, and partnerships with companies commercializing medical devices.
Dr. N. Kalaiselvi, Secretary of the Department of Scientific and Industrial Research and Director General of the Council of Scientific and Industrial Research, inaugurated the sustainable phase. She emphasized that the transition shows the program’s intended outcome: serving industry and innovators without ongoing government support.
From Grant Dependency to Industry Revenue
The hub’s shift reflects a deliberate strategy to build a lasting research facility. Rather than closing after initial funding ended, the center restructured to attract paying clients and corporate partners willing to fund technology development.
The model reserves capacity for small and medium-sized enterprises, startups, and independent innovators. These groups still receive access to state-of-the-art infrastructure, technical expertise, and development support. The hub charges user fees to sustain laboratory operations, equipment maintenance, and staff salaries.
Kalaiselvi highlighted that the network of similar research hubs strengthens India’s indigenous medical device capability. She argued that wider use of these shared facilities would reduce dependence on imported technology and build domestic expertise in medtech.
Track Record and Real-World Deployment
The CRTDH has already facilitated more than 20 technology transfers from research to commercial production. Many of these devices have been commercialized and entered clinical use. The hub also partnered with clinical organizations and nonprofits to establish rural health units that deploy affordable technologies in remote areas.
Suman Chakraborty, Director of IIT Kharagpur, highlighted the importance of frugal engineering for real-world healthcare. He explained that designing technologies for settings with limited infrastructure and for use by frontline health workers requires robust, accessible solutions.
This focus on constraint-based design, building devices that work without sophisticated support systems, distinguishes the hub’s approach. Many global medical devices depend on specialized infrastructure, training, or supply chains unavailable in rural India.
What Self-Sustainability Means for Innovation Access
The transition carries both opportunities and risks for startups and small innovators. Access to the facility remains available, but projects now compete for slots based on commercial viability and ability to pay user fees. Startups with venture funding or industry backing may find easier entry than early-stage researchers with limited capital.
The hub’s focus on frugal innovation and rural deployment addresses a genuine gap. India’s public health system serves hundreds of millions of patients in areas where conventional medical technology is impractical or unaffordable. Devices designed for low-resource settings can reduce patient burden and improve diagnostic access in underserved regions.
The CRTDH now operates as a shared platform where device makers, researchers, and clinical partners collaborate on commercialization. This structure differs from traditional university research, where intellectual property often remains locked in academic publication.
Implications for Medtech Innovation
The shift to self-sustainability suggests that publicly funded research facilities can transition to market-based operation when innovation reaches maturity. The model also demonstrates that there is commercial interest in affordable healthcare technology development, a sector often overlooked by venture capital focused on high-margin devices for wealthy markets.
The continued operation of the CRTDH beyond government support shows that industry, academia collaboration on medtech can be profitable. Companies seeking low-cost manufacturing, regulatory guidance, or prototype development have incentive to pay for access to laboratory facilities and expert staff.
Kalaiselvi noted that the hub’s success illustrates how government seed funding for research infrastructure can catalyze self-sustaining innovation ecosystems. Once the initial facility is built and a track record established, private and commercial funding can sustain the work.
The remaining open question is whether this model will be replicated at other research institutions across India. The CRTDH’s transition may serve as a template for moving government-supported technology hubs toward independence, or it may remain a unique case dependent on IIT Kharagpur’s reputation and the specific demand for affordable medical devices in rural India.
The facility continues accepting new projects from innovators, startups, and companies seeking to develop and commercialize cost-effective medical technologies. Researchers and entrepreneurs interested in deploying healthcare solutions in resource-limited settings can access the hub’s infrastructure on a fee basis, ensuring the center remains available to the ecosystem it was designed to serve.
